Publications

Browse Publications:

By Category:

• Abstract Posters (8)
• Research Papers (134)
• Presentations (6)

By Physician:

• David Charytan, MD (9)
• Donald E. Cutlip, MD (76)
• Ralph D'Agostino, PhD (15)
• Elazer R. Edelman, MD, PhD (5)
• Maurizio Fava, MD (5)
• Lawrence Garcia, MD (0)
• Ernest V. Gervino, Sc.D., FACSM (1)
• Michael Gibson, MD (4)
• Kalon K.L. Ho, MD, MSc (21)
• Michael Jaff, MD (0)
• Mark Josephson, MD (11)
• Joseph Massaro, PhD (18)
• Laura Mauri, MD (35)
• Andrew Nierenberg, MD (0)
• Mark H. Pollack, MD (1)
• Jeffrey J. Popma, MD (46)
• Matthew R. Reynolds, M.D, M.Sc. (18)
• Alexei Shvilkin, MD, PhD (14)
• Peter Zimetbaum, MD (30)

Publications From: Joseph Massaro, PhD

Pericardial Fat Volume Correlates With Inflammatory Markers: The Framingham Heart Study. Obesity (Silver Spring). 2009 Oct 29. [Epub ahead of print]

Claudication: exercise vs endoluminal revascularization (CLEVER) study update. J Vasc Surg. 2009 Oct;50(4):942-945.e2.

Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study). Am J Cardiol. 2009 Aug 15;104(4):543-7.

Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ Arrhythm Electrophysiol. 2009 Apr;2(2):113-9.

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J. 2009 Apr;30(7):850-6.

Patterns of Abdominal Fat Distribution: The Framingham Heart Study. Diabetes Care. 2008 Dec 15.

Association of Lifestyle Factors with Abdominal Subcutaneous and Visceral Adiposity: The Framingham Heart Study. Diabetes Care. 2008 Dec 15.

Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study. Am Heart J. 2008 Nov;156(5):1003-1009.e1.

Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease. The Framingham Offspring Study. Circulation. 2008 Nov 24.

Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol. 2008 Oct;65(10):1363-7.

A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008 Jun;1(3):248-57.

The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007 Oct 9;50(15):1442-9.

Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007 Mar 8;356(10):1020-9.

Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J. 2005 Nov;150(5):887-92.

Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008 Apr 10;358(15):1572-9.

Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004 Sep 7;110(10):1226-30.

Trajectories of Entering the Metabolic Syndrome. The Framingham Heart Study. Circulation. 2009 Nov 2. [Epub ahead of print]

Seronegative autoimmune diseases. Ann N Y Acad Sci. 2009 Sep;1173:52-9.

Meet The HCRI Team

Matthew Reynolds, MD

Director of the Economics and Quality of Life Research Center

Dr. Matthew Reynolds is board-certified in Cardiovascular Medicine and Clinical Cardiac Electrophysiology and performs cost-effectiveness…

Submit an RFP

Quick Links

• Contact HCRI
• Careers at HCRI
• Information for Patients

930-W Commonwealth Avenue
Boston MA 02215
t: 617.632.1515    f: 617.632.1580

©2009 Harvard Clinical Research Institute